Skip to main content
. 2018 Mar 26;59(6):967–973. doi: 10.1194/jlr.M080952

Fig. 3.

Fig. 3.

Overexpression SIRT3 improves NAFLD in MTP+/− mice. A: Overexpression of SIRT3 in WT and MTP+/− mice. B: Quantification of hepatic SIRT3 levels in WT type and MTP+/− mice injected with β-gal or SIRT3 adenovirus. C: ALT levels. D: Hepatic triglyceride (TAG). E: Oil Red O (ORO) and H&E staining of liver sections from MTP+/− mice injected with β-gal or SIRT3 adenovirus. F: Staining of liver sections from MTP+/− mice injected with β-gal or SIRT3 adenovirus. Data are mean ± SE; n = 3–6. #, difference between WT β-gal and WT SIRT3; *, difference between WT-β-gal and MTP+/−-β-gal; &, difference between MTP+/−-β-gal and MTP+/−- SIRT3.